NeuroMetrix gets FDA approval to market its Sensus pain-management device in the US - The Boston Globe
Links shared publicly online about this topic.
- 24total visits
NeuroMetrix gets FDA approval to market its Sensus pain-management device in the US - The Boston Globe
NeuroMetrix Inc., a medical device company based in Waltham, said its Sensus pain management device has been approved by the Food and Drug Administration. The company added that it now hopes that the device should reach the US market before the end of the year. The Sensus is a non-invasive electrical nerve stimulator that is designed to provide relief from chronic pain. People likely to benefit from the device are diabetics with nerve-related complications.
View full resource at boston.com
Most Recently Shared on August 8, 2012 at 1:17 pm By:
Pain-management device is cleared: NeuroMetrix Inc., a medical device company based in Waltham, said its Sensus ... http://t.co/UltRhD5F
Advertisement
